93
Participants
Start Date
July 25, 2018
Primary Completion Date
January 17, 2020
Study Completion Date
May 26, 2020
Blood collection for research (next-generation sequencing [NGS])
Participants will have whole blood collected for next-generation sequencing (NGS).
Blood collection for research (HLA typing)
Participants will have whole blood collected for HLA typing.
Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, New York
Virginia Cancer Specialists, Fairfax
Tennessee Oncology, Nashville
The Ohio State University Comprehensive Cancer Center, Columbus
University of Chicago Medicine Comprehensive Cancer Center, Chicago
Lead Sponsor
Gritstone bio, Inc.
INDUSTRY